These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28738904)

  • 21. Yes, research matters.
    Shinohara ML
    PLoS Pathog; 2017 Aug; 13(8):e1006420. PubMed ID: 28796840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study.
    Agrawal A; Nelson EC; Bucholz KK; Tillman R; Grucza RA; Statham DJ; Madden PA; Martin NG; Heath AC; Lynskey MT
    Lancet Psychiatry; 2017 Sep; 4(9):706-714. PubMed ID: 28750823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic mild stress exacerbates severity of experimental autoimmune encephalomyelitis in association with altered non-coding RNA and metabolic biomarkers.
    Gerrard B; Singh V; Babenko O; Gauthier I; Wee Yong V; Kovalchuk I; Luczak A; Metz GAS
    Neuroscience; 2017 Sep; 359():299-307. PubMed ID: 28739526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocortins, Melanocortin Receptors and Multiple Sclerosis.
    Lisak RP; Benjamins JA
    Brain Sci; 2017 Aug; 7(8):. PubMed ID: 28805746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives.
    Coyle PK
    Mult Scler Int; 2017; 2017():6198530. PubMed ID: 28804651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.
    Abdelhak A; Hottenrott T; Mayer C; Hintereder G; Zettl UK; Stich O; Tumani H
    PLoS One; 2017; 12(8):e0182647. PubMed ID: 28797088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action.
    Balasa RI; Simu M; Voidazan S; Barcutean LI; Bajko Z; Hutanu A; Simu I; Maier S
    CNS Neurol Disord Drug Targets; 2017; 16(9):1018-1026. PubMed ID: 28782487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.
    Vavasour IM; Huijskens SC; Li DK; Traboulsee AL; Mädler B; Kolind SH; Rauscher A; Moore GW; MacKay AL; Laule C
    Mult Scler; 2018 Oct; 24(12):1557-1568. PubMed ID: 28782447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced cuprizone-induced cerebellar demyelination in mice with astrocyte-targeted production of IL-6 is associated with chronically activated, but less responsive microglia.
    Petković F; Campbell IL; Gonzalez B; Castellano B
    J Neuroimmunol; 2017 Sep; 310():97-102. PubMed ID: 28778453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients.
    Mathur D; Riffo-Campos AL; Castillo J; Haines JD; Vidaurre OG; Zhang F; Coret-Ferrer F; Casaccia P; Casanova B; Lopez-Rodas G
    Front Cell Neurosci; 2017; 11():209. PubMed ID: 28775680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases.
    Saldanha IJ; Lindsley K; Do DV; Chuck RS; Meyerle C; Jones LS; Coleman AL; Jampel HD; Dickersin K; Virgili G
    JAMA Ophthalmol; 2017 Sep; 135(9):933-940. PubMed ID: 28772305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of Gamma-Irradiated Corneal Patch Graft Thickness After Aqueous Drainage Device Surgery.
    de Luna RA; Moledina A; Wang J; Jampel HD
    JAMA Ophthalmol; 2017 Sep; 135(9):941-946. PubMed ID: 28772298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-Dependent Cross-Brain Information Flow in Borderline Personality Disorder.
    Bilek E; Stößel G; Schäfer A; Clement L; Ruf M; Robnik L; Neukel C; Tost H; Kirsch P; Meyer-Lindenberg A
    JAMA Psychiatry; 2017 Sep; 74(9):949-957. PubMed ID: 28768322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia.
    Kochunov P; Coyle TR; Rowland LM; Jahanshad N; Thompson PM; Kelly S; Du X; Sampath H; Bruce H; Chiappelli J; Ryan M; Fisseha F; Savransky A; Adhikari B; Chen S; Paciga SA; Whelan CD; Xie Z; Hyde CL; Chen X; Schubert CR; O'Donnell P; Hong LE
    JAMA Psychiatry; 2017 Sep; 74(9):958-966. PubMed ID: 28768312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual loss due to optic nerve infarction and central retinal artery occlusion after spine surgery in the prone position: A case report.
    Lee SH; Chung I; Choi DS; Shin IW; Kim S; Kang S; Kim JY; Chung YK; Sohn JT
    Medicine (Baltimore); 2017 Aug; 96(31):e7379. PubMed ID: 28767569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding.
    Voskuhl R; Momtazee C
    Neurotherapeutics; 2017 Oct; 14(4):974-984. PubMed ID: 28766273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unilateral tongue myokymia - A rare topodiagnostic sign of different clinical conditions.
    Leupold D; Schilg L; Felbecker A; Kim OC; Tettenborn B; Hundsberger T
    J Clin Neurosci; 2017 Nov; 45():132-133. PubMed ID: 28765061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side-effects associated with ketamine use in depression: a systematic review.
    Short B; Fong J; Galvez V; Shelker W; Loo CK
    Lancet Psychiatry; 2018 Jan; 5(1):65-78. PubMed ID: 28757132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule.
    Watanabe N; Suzuki Y; Yonezu T; Nakagawa Y; Shiina T; Hirayama N; Inokuchi S; Inoue S
    Sci Rep; 2017 Jul; 7(1):6798. PubMed ID: 28754892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.